Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Jeffrey A. Cohen, Brenda Banwell et al.|The Lancet Neurology|2017Cited by 8k
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosisLeonora Fisniku, David H. Miller, P A Brex et al.|Brain|2008Cited by 894
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple SclerosisPeter Brex, David H. Miller, Olga Ciccarelli et al.|New England Journal of Medicine|2002Cited by 863
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalbán, Frauke Zipp, Tobias Derfuß et al.|Multiple Sclerosis Journal|2018Cited by 706
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Siddharthan Chandran, Madhan Kolappan et al.|The Lancet Neurology|2012Cited by 606